Biotech Values

[mcbio]

Thx for feedback. Based on JNP's CC, management thinks the future of the company lies in the newly in-licensed (potentially multi-drug) IVR.

You're generally a bit skeptical on companies that try to re-brand themselves through a name change, aren't you? A name change and in-licensing a drug (as opposed to internal prowess)? I might need some extra convincing. ; )